BIP : The Institut Pasteur Newsletter, February 4, 2022

Teams at the Institut Pasteur, CNRS, Vaccine Research Institute (VRI) and Université de Paris have discovered a new function of anti-HIV-1  antibodies by applying cutting-edge microscopy techniques to in vitro viral cultures.

The COVID-19 pandemic, which has afflicted the world for more than two years, is caused by SARS-CoV-2. The genome of this respiratory virus is composed of a single strand of RNA, a molecule similar to DNA that enables the virus to replicate in the body.

In March 2021, the Institut Pasteur and the Paris Public Hospital Network (AP-HP) signed a three-year collaboration agreement with Janssen Biotech, the R&D partner of Janssen France, one of the pharmaceutical companies in the Johnson & Johnson, Inc. group. The agreement has already led to several successful collaborative projects between the Institut Pasteur and Johnson & Johnson, one of the key accounts managed by the Technology Transfer and Industrial Partnership Department (DARRI).

IT, information systems security, data management and open data... These issues are important for your unit, and you are having trouble finding the right contacts?

A website presenting best practices for medical monitoring of biological risks in research laboratories, aimed at occupational health professionals, has been developed and recently launched by the Institut Pasteur's Occupational Health Department.